高視醫療(02407.HK):人工晶狀體植入系統獲得中國醫療器械註冊證
格隆匯5月9日丨高視醫療(02407.HK)發佈公吿,近日,公司全資附屬公司高視泰靚醫療科技有限公司(“高視泰靚”)的“人工晶狀體植入系統”已獲得由廣東省藥品監督管理局批准的醫療器械註冊證。
高視泰靚本次獲批的人工晶狀體植入系統(註冊證編號:粵械注準20252160605),主要適用於微小切口白內障手術中的人工晶狀體植入手術。與2024年獲批的人工晶狀體植入系統(註冊證編號:粵械注準20242161490)相比,其將手術切口優化至 1.8mm以內,能夠最大限度減少角膜創傷及加速術後恢復,同時其導入頭表面通過使用化學接枝潤滑塗層技術,實現了晶體推注超低阻力和手術效率顯著提升。
該產品為高視泰靚原創設計,並且已獲得發明專利授權,該發明專利的技術特徵為既可以將不同型號規格的導入頭安裝在其主體套管上,以用於不同手術切口大小的晶狀體植入使用,同時也能拓展為預裝式植入系統,以適配市面上所有類型的人工晶狀體進行人工晶狀體植入手術。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.